Responsiveness of disease-specific and generic utility instruments in prostate cancer patients

@article{Krahn2006ResponsivenessOD,
  title={Responsiveness of disease-specific and generic utility instruments in prostate cancer patients},
  author={Murray D. Krahn and Karen E Bremner and George Tomlinson and Paul Ritvo and Jane Irvine and Gary Naglie},
  journal={Quality of Life Research},
  year={2006},
  volume={16},
  pages={509-522}
}
Preferences (utilities) for health outcomes have an important role in decisions about prostate cancer screening and treatment. The responsiveness of utility instruments has not been evaluated. Prostate cancer outpatients from the Princess Margaret Hospital, Toronto (n = 248) were allocated into three cohorts: N — newly diagnosed and treated; M — metastatic disease; O — all others. We measured quality of life at 3 points within 12 months using 3 disease-specific utility instruments (Patient… CONTINUE READING